Haemonetics (HAE) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Haemonetics Corporation  (NYSE: HAE)

Select the Financial Report: Select the Period:


Description of Haemonetics's Business Segments


Haemonetics Corporation is a prominent global entity specializing in blood management solutions, catering to hospitals, blood banks, and plasma collection centers. The organization has divided its offerings into various segments, products, and services aimed at enhancing patient outcomes and optimizing operational efficiencies within the healthcare sector. Here’s an extensive breakdown of Haemonetics’ segments, products, and services:

Segments:

1. Blood Center:
- This segment is dedicated to offering innovative solutions for blood banks and plasma collection centers around the globe. Haemonetics focuses on advanced technologies for blood collection and processing that ensure the quality, safety, and efficacy of blood components. Solutions in this segment also aim to streamline operations and improve yield from donations, thereby increasing the overall efficiency of blood centers.

2. Hospital:
- The hospital segment provides comprehensive blood management systems designed to oversee and improve the entire blood supply chain within healthcare facilities. This can include tools for blood ordering and tracking, as well as efficient inventory management systems. These solutions help minimize blood waste, ensure timely availability for patients, and ultimately improve clinical outcomes.

Products:

1. Cell Saver Elite+:
- The Cell Saver Elite+ is a state-of-the-art cell salvage system that allows for efficient collection of a patient’s own blood during surgical procedures. It features advanced volume reduction technologies and patient safety mechanisms, making it an essential tool in surgeries that have a high risk of blood loss, thereby facilitating a more effective recovery and reducing the need for donor blood.

2. TEG 6s:
- The TEG 6s (Thromboelastography) analyzer is a cutting-edge diagnostic tool used by healthcare professionals to monitor patients hemostatic (clotting) functions. This instrument allows for the real-time assessment of a patients responsiveness to various anticoagulant and antiplatelet therapies, enabling tailored treatment plans and better management of bleeding risks during surgery or critical care.

3. Plasma Collection:
- Haemonetics provides a comprehensive suite of technologies and devices tailored for plasma collection centers. These solutions include user-friendly interfaces and equipment designed to enhance the donor experience while ensuring optimal plasma collection processes. The emphasis is on improving efficiency, safety, and quality in plasma collection.

4. Blood Collection:
- The companys blood collection solutions encompass a range of products such as automated blood collection systems, sterile blood bags, and specialized needles. These products are engineered to enhance the efficacy and safety of the blood donation process, reduce contamination risk, and improve the overall donor experience.

Services:

1. Consulting Services:
- Haemonetics offers expert consulting services that assist hospitals and blood centers in refining their blood management practices. This could include analysis of existing workflows, strategies for improving donation rates, and implementation of best practices in blood usage, ultimately aiming to enhance operational efficiencies and patient care outcomes.

2. Technical Services:
- The technical services offered by Haemonetics ensure that their products and equipment remain functional and reliable. This includes on-site support, maintenance services, and troubleshooting, which are vital for minimizing downtime and ensuring that blood management systems operate at peak performance.

3. Education and Training:
- The education and training services provided by Haemonetics are designed to empower healthcare personnel with the knowledge and skills necessary to leverage the company’s products effectively. By offering training sessions, workshops, and educational materials, Haemonetics supports hospitals and blood banks in maximizing the benefits of their blood management solutions, thereby fostering a culture of continuous improvement and excellence in patient care.

Conclusion:

Overall, Haemonetics Corporation’s diverse range of segments, products, and services is meticulously designed to enhance the quality and efficiency of blood management solutions. By focusing on innovation and the specific needs of hospitals, blood banks, and plasma collection centers, Haemonetics continues to play a pivotal role in advancing patient outcomes and optimizing healthcare operational practices globally.


Composition of Haemonetics Corporation Revenues by Segments

 
Apheresis    56.37 % of total Revenue
MedSurg    43.63 % of total Revenue
United States    75.98 % of total Revenue
Japan    3.79 % of total Revenue
Europe    13.42 % of total Revenue
Asia    5.94 % of total Revenue
Other Country or Region    0.88 % of total Revenue

Q1 three months ended (Jun 27 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Apheresis 191.32 56.37 %
MedSurg 148.06 43.63 %
United States 257.84 75.98 %
Japan 12.86 3.79 %
Europe 45.53 13.42 %
Asia 20.16 5.94 %
Other Country or Region 2.99 0.88 %
Total 339.38 100 %




Q1 three months ended (Jun 27 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Apheresis - -
MedSurg - -
United States 6.37 % -
Japan -5.79 % -
Europe 11.37 % -
Asia - -
Other Country or Region - -
Total 5.65 % -74.55 %




Q1 three months ended (Jun 27 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Apheresis 56.55 29.56 %
MedSurg 22.71 15.34 %
Segment Reporting, Reconciling Item, Corporate Nonsegment 57.46 -
Total 33.01 9.73 %




Q1 three months ended (Jun 27 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Apheresis - -
MedSurg - -
Segment Reporting, Reconciling Item, Corporate Nonsegment - -
Total -3 % -66.08 %




Annual Report on Haemonetics Corporation Divisions, Sales by Country

 
United States   United States Segment contribution to total sales 73.65 % of total Revenue
Japan   Japan Segment contribution to total sales 5.11 % of total Revenue
Europe   Europe Segment contribution to total sales 13.87 % of total Revenue
Rest of Asia   Rest of Asia Segment contribution to total sales 6.54 % of total Revenue
Other   Other Segment contribution to total sales 0.86 % of total Revenue
Plasma   Plasma Segment contribution to total sales 39.33 % of total Revenue
Blood Center   Blood Center Segment contribution to total sales 16.59 % of total Revenue
Hospital   Hospital Segment contribution to total sales 44.11 % of total Revenue


Twelve months ended 2026
HAE s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
United States 982.18 73.65 %
Japan 68.20 5.11 %
Europe 185.02 13.87 %
Total 1,333.59 100 %
Rest of Asia 87.21 6.54 %
Other 11.42 0.86 %
Plasma 524.46 39.33 %
Blood Center 221.27 16.59 %
Hospital 588.30 44.11 %


Twelve months ended 2026
HAE s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 97.31 7.3 %

Twelve months ended 2026
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
United States -2.84 % -
Japan 9.28 % -
Europe 5.33 % -
Total -1.94 % -41.97 %
Rest of Asia -5.52 % -
Other -41.55 % -
Plasma -2.05 % -
Plasma Plasma - -
Blood Center -15.26 % -
Hospital 4.26 % -
Blood Center Blood Center - -
Hospital Hospital - -
Apheresis Blood Center - -
Whole Blood Blood Center - -
Interventional Technologies Hospital - -
Blood Management Technologies Hospital - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.